5/16/2023 0 Comments Flowstate microdose![]() ![]() Microdosing is being used to reduce feelings of anxiety and depression, and to combat the effects of PTSD, addiction, and various mood disorders. A trip dose of mushrooms for a person of average height and weight is approximately 2 grams. This dose is designed to be sub-perceptual, you will not trip, hallucinate, or feel high, but you should feel a “glow.” For example, in our Reset capsules, we use 100 mg of Vancouver Island grown golden teacher psilocybin mushrooms. But I’m confident that you’re going to find the newsletter an engaging and indispensable tool for navigating the crosscurrents of the psychedelic renaissance.Microdosing is the act of taking a very small dose, often 5%-10% of a normal “trip” dose of a psychedelic substance. I hope you’ll give The Microdose a try and subscribe. I will also be involved, contributing my perspective and the occasional item. Overseeing The Microdose is Malia Wollan, the Berkeley Center’s editor-in-chief, a long-time colleague of mine at the Graduate School of Journalism and a contributing writer at the New York Times Magazine. Before becoming a journalist, Jane was a psychology researcher she holds a Ph.D. Her work has appeared in national publications such as Slate, WIRED, National Geographic, The Atlantic, Outside, Science, and High Country News. Hu is an award-winning science journalist living in Seattle. I’m pleased to introduce you to the head writer of The Microdose. Psychedelics is not yet a full-blown journalistic beat but it deserves to be one, and Berkeley aims to help make that happen. Berkeley’s Graduate School of Journalism, the public education program aims to do what independent journalism does best: inform, enlighten, and hold the burgeoning new field accountable. The newsletter is just the first initiative in a program that will eventually include a massive online course (“Psychedelic Science 101”) a fellowship to fund journalists working on important stories about psychedelics a podcast and a website rich with resources on psychedelics. Berkeley Center for the Science of Psychedelics, which in addition to conducting basic and social scientific research into psychedelics and training psychedelic guides, has committed itself to a robust program of public education. The Microdose comes courtesy of the newly established U.C. Our goal is to keep you up-to-date and informed, whether you’re in the field or simply curious. On Mondays, an installment will offer a Q & A with a newsmaker in the field-it might be a person you’ve heard of or someone you need to know about. Which is precisely why, on behalf of Berkeley Center for the Science of Psychedelics, we’re delighted to welcome you to our twice-weekly newsletter, The Microdose.Įvery Friday, The Microdose will bring you a handful of brief takes on developments in the field of psychedelics, covering everything from scientific research and policy to business and culture. Things are moving so quickly on so many different fronts that keeping up with developments in the field has become challenging. If proof of the promise and legitimacy of psychedelic research were still needed, it has arrived. Since 2018, a dozen universities-including Johns Hopkins, NYU, Berkeley, Yale, and Harvard-have launched research centers dedicated to studying psychedelics, all funded by private philanthropy.īut then in October 2021, the National Institute of Health (NIH) made its first substantial grant for a psychedelic drug trial in more than fifty years to John Hopkins, for a study of psilocybin-assisted psychotherapy for tobacco addiction. (A handful of these companies have already gone public, with billion-dollar valuations.) FDA approval of MDMA and psilocybin may be only a few short years away. That research has already spawned an entirely new industry, with hundreds of startups, all with different ideas of how best to commercialize psychedelics. What just a few years ago was an obscure corner of clinical and neuroscientific research has blossomed into a vibrant scientific field, yielding promising new treatments and important insights about the mind and brain. There has never been a more exciting-or bewildering-time in the world of psychedelics. ![]()
0 Comments
Leave a Reply. |